Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Learn more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results